Brinton Pharmaceuticals on Thursday said it has received approval from the Drugs Controller General of India to launch Favipiravir 400 mg tablets under the brand name Faviton for Rs 79 per tablet. The tablets are indicated for the treatment of patients with mild to moderate COVID-19 symptoms, Brinton Pharmaceuticals said in a statement. The tablets will be available across all …
)